Connect with us

Technology

Grow Therapy Launches a National Campaign Reframing Therapy as a Practice for Progress

Published

3 months ago

on

Four musical films capture the personal growth that unfolds when people care for their mental health

NEW YORK, Aug. 24, 2026 /PRNewswire/ — Grow Therapy (Grow) today launched “Key Change,” its first national brand campaign, reframing a pervasive assumption: that mental health care is something earned by reaching a breaking point.

People have internalized this belief. In the latest national survey, 73% of adults who believed they needed mental health care but didn’t get it said it was because they thought they should be able to handle it on their own. It is as if people have to be deemed sick enough to deserve support.

“Key Change” was made to break that pattern. The campaign’s premise is simple and hopeful: therapy can strengthen how people respond to their feelings, creating small but compounding moments of emotional progress. Instead of dramatic breakdowns or before-and-after arcs, the films celebrate the self-awareness that subtly takes shape when people find the right therapist.

“A lot of mental health marketing depicts therapy only as a fix for when life falls apart. We wanted to challenge that assumption,” said Marshall Ball, SVP of Marketing at Grow Therapy. “Many of our clients come to therapy to build the self-awareness, strength, and resilience to navigate the types of challenges we all face throughout life, with incredible support from a qualified therapist they can afford through their insurance. We want to show people that Grow can play a meaningful role in turning those tests into personal growth and building the life you want.”

For this campaign, Grow chose KDSP (Kirby, Dryer, Sullivan & Partesotti), a senior-led creative agency led by four of advertising’s most awarded and trusted minds, as its strategic and creative partner to lead the development of the brand strategy and foundations, creative platform, campaign development, and integrated production. Grow set a creative standard for the work: it had to capture universal human experiences while revealing the layered and complex inner life underneath.

“Therapy helps you to bring awareness to the little moments in your life where your choices matter. We built our campaign on that,” said Katie O’Keefe, Senior Creative Director at Grow Therapy. “Each film is a moment that will feel familiar to many, but it’s experienced through one person’s highly specific inner monologue. You’re inside their head as they catch an old pattern and choose how to respond instead of reacting.”

Each film is built around an original song that transforms alongside its protagonist. At the moment each character’s point of view shifts, the music rises with them, moving from understated to confident as the work of therapy shows up in the moment. A couple chooses a conversation over silent treatment. A woman chooses mindfulness by observing her thoughts rather than ruminating. A father chooses empathy. A daughter chooses not to give in to passive aggression. Music works as emotional architecture: the song carries the deeper feelings of each character as the camera follows them through an ordinary day.

“Much of the mental health category is built around a problem-and-solution story: something is wrong, therapy fixes it, and you feel better,” said Mollie Partesotti, Co-Founder, Strategy at KDSP. “But that is not how progress actually works. With Grow, we wanted to show the smaller, more human shifts that therapy can make possible. Choosing connection instead of criticism. Holding a boundary with kindness. Returning to a conversation instead of retreating from it. These moments may look small, but they can change the direction of a life.”

“Key Change” is airing in 20 markets, on TV and streaming. Visit Grow’s YouTube channel to watch each film: The Bait; The Other Room; Sports Dad; Hot Dog.

About Grow: 
Grow is a mental health platform that delivers exceptional in-person and online therapy and psychiatric care. Its rigorously vetted national network of 27,000 mental health professionals provides high-quality care covered by insurance, with 230 million Americans able to access Grow through their health plan. Grow Therapy has raised $328 million, and key investors include Sequoia Capital, Goldman Sachs Alternatives, Transformation Capital, TCV, SignalFire, Plus Capital, BCI and Menlo Ventures. More information about Grow Therapy can be found at growtherapy.com.

Media Contact: Kristina McPherson, kristina@growtherapy.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/grow-therapy-launches-a-national-campaign-reframing-therapy-as-a-practice-for-progress-302857598.html

SOURCE Grow Therapy

Related Topics:
Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

2 hours ago

on

November 14, 2026

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Technology

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

Published

3 hours ago

on

November 14, 2026

By

gtinfetch.ai, WeFetch.ai’s lead product, removes the guess from artificial intelligence (AI) shopping: the right barcode, and signed proof of it.

VANCOUVER, BC and LONDON, Nov. 13, 2026 /PRNewswire/ — WeFetch AI Corp., the artificial intelligence (AI) shopping company formerly named GreenCore Solutions Corp., has completed its change of name. The Registrar of Companies for British Columbia issued the Certificate of Change of Name on November 13, 2026.

One Answer for Every Barcode

An AI agent picks a product in words. The same words can match a dozen barcodes: the right brand in the wrong size, last year’s pack, a look-alike from another maker. When the agent guesses, the shopper gets the wrong product, the brand loses a sale it had already won, and the retailer pays for the return.

The Company’s lead product, gtinfetch.ai, removes the guess. It answers for 84,810,515 barcodes from 376,271 makers across 3,520,471 points of sale. An AI agent sends a barcode and gets a firm answer: verified, not verified or unknown, with the sources behind it.

Who it matters to:

The shopper gets the product they asked for.The brand keeps the sale the AI already gave it.The retailer does not pay for a wrong order.

A Signed Receipt of Every Check

When an AI agent buys on a shopper’s behalf, someone has to be able to show it bought the right product. Today nobody can: the agent’s choice leaves no record. gtinfetch.ai gives the agent a signed receipt of the check, written at rco.wefetch.ai and open to public verification. The retailer, the brand and the auditor can each see what was checked, when, and what the answer was. The mark is “Barcode verified”.

Three Regions, One Record

The full record now answers from France, Singapore and the United States. Every barcode also has its own free public page at gtinfetch.ai. The three regions are where AI shopping starts. Singapore has the highest consumer use of generative AI in Asia, at 64.3% of working-age people. France stands at 49.6% and the United States at 33.0%, against 18.8% worldwide. (Source: Microsoft AI Diffusion Report, Q2 2026.) They are also the home markets of the AI that shoppers ask: ChatGPT and Claude in the United States, Mistral in France, and Singapore among the top countries in the world for Claude use per head. (Source: Anthropic Economic Index.)

What we built

WeFetch.ai, the barcode fetch system for AI agents. It answers for 84 million products in 70 countries, with 3.5 million points of sale on its own record, and includes:

triggerfetch for brands;shopfetch for shoppers;matchfetch for AI agents;gtinfetch, the record itself.

It is AI native, and works with ChatGPT, Claude, Gemini, Grok, Mistral, Perplexity and Muse. Every answer is signed.

“Words were the first generation of AI answers. Barcodes are agentic commerce,” said Matthew Keddy, Chief Executive Officer of WeFetch AI Corp. “Every AI agent that moves from search results to shopping needs barcode precision. wefetch has it, signed, in three regions.”

The market: Gartner forecasts $2.7 trillion in AI spending in 2026. McKinsey projects that AI agents will orchestrate $3 trillion to $5 trillion in global commerce by 2030, up to $1 trillion of it in US retail. Every one of those AI agent purchases needs the right barcode.

About WeFetch AI Corp.

WeFetch AI Corp. develops AI software products for AI shopping, retail, grocery and fast-moving consumer goods (FMCG). Its lead product, gtinfetch.ai, is the AI agentic shopping barcode engine: 84 million barcodes, answered for the agents of seven AI labs. WeFetch is headquartered in Vancouver, Canada, with sales offices in London, UK. Please visit: wefetch.ai

View original content:https://www.prnewswire.com/news-releases/wefetch-ai-corp-is-the-new-name-of-greencore-solutions-corp-302939459.html

SOURCE Greencore Solutions Corp.

Continue Reading

Technology

/C O R R E C T I O N – BTQ Technologies Corp./

Published

4 hours ago

on

November 14, 2026

By

In the news release, BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update, issued Nov. 13, 2026 by BTQ Technologies Corp. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows:

BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update

VANCOUVER, BC, Nov. 13, 2026 /PRNewswire/ — BTQ Technologies Corp. (“BTQ” or the “Company”) (Nasdaq: BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, November 17, 2026, at 11:00 a.m. EST to discuss its quarterly financial results and provide a general corporate update. The call will follow the release of the Company’s Q3 2026 financial statements, which will be issued after market close on Monday, November 16, 2026.

IMPORTANT – To register for the webcast see below:

When: November 17, 2026
Time: 11:00 AM Eastern Time
Topic: BTQ Technologies Shareholder Call to Discuss Q3 2026 Financial Results and Corporate Update

Register in advance for this webinar:
https://us06web.zoom.us/webinar/register/WN_n6WGI3lERpCZcA63pWQWVQ 

After registering, you will receive a confirmation email containing information about joining the webinar.

About BTQ
BTQ Technologies Corp. (Nasdaq: BTQ | Cboe CA: BTQ) is a quantum technology company focused on accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio and deep technical expertise, BTQ is developing a full-stack, neutral-atom quantum computing platform spanning hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense.

Connect with BTQ: Website | LinkedIn | X/Twitter

ON BEHALF OF THE BOARD OF DIRECTORS
Olivier Roussy Newton
CEO, Chairman

Neither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Information

Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as “anticipate”, “intend”, “expect”, “plan” or “may” and the variations of these words are intended to identify forward-looking statements and information.

The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive.

Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company’s research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Correction: An earlier version of this release incorrectly [describe the update briefly].

View original content to download multimedia:https://www.prnewswire.com/news-releases/btq-technologies-to-host-live-webinar-on-q3-2026-financial-results-and-general-corporate-update-302939440.html

SOURCE BTQ Technologies Corp.

Continue Reading

Trending